Trump Administration Faces Backlash Over Tylenol and Autism Claims

The Trump administration's recent claims linking Tylenol to autism have ignited significant backlash from medical professionals and expectant mothers. Critics argue that the guidance is based on inconclusive studies and misrepresents established research, raising concerns about misinformation in health policies. This controversy underscores the potential impact on public health and the importance of reliable information for vulnerable populations.